TAVI Hotline: new devices, new approaches
Interventions for Valvular Disease
Hotline / Late-Breaking Trials
Theatre Havane
Anchorperson: Kentaro Hayashida
Spokesperson: Tiffany Patterson
Discussants: Philippe Genereux, Howard Herrmann, Radoslaw Parma, Sondos Samargandy
Introduction
Kentaro Hayashida
First report of an IDE pivotal study of a dedicated splitting device during TAVR
Danny Dvir
Discussion and audience interaction
Upper extremity versus lower extremity for accessory access sites during TAVI
Geert Versteeg
Discussion and audience interaction
DurAVR biomimetic transcatheter heart valve: early feasibility and first-in-human trial update
Christopher Meduri
Discussion and audience interaction
One-year efficacy and safety of the dry-pericardium aortic valve: A first-in-human feasibility study
Kasparas Briedis
Discussion and audience interaction
Using temporary permanent pacemaker as a one-month bridge after TAVI
Guangyuan Song
Discussion and audience interaction
Clinical evaluation of the Hydra self-expanding THV: 30 days results from the GENESIS-II study
Nagendra Boopathy Senguttuvan
Discussion and audience interaction
Conclusion
Tiffany Patterson